---

$114.32

+10.7200 ( +10.35% ) 629.5K

Veradermics Inc clinical-stage biopharmaceutical company focused on developing therapeutics to address pervasive treatment challenges in highly prevalent aesthetic and dermatological conditions. The company operates in a single segment of allocating resources, assessing performance, and making operating decisions.

Open	$114.32
Previous Close	$103.60
Volume	629.5K
Market Cap	$4.33B
Day Range	$103.32 - $115.18
52 Week Range	$32.00 - $117.71
Shares Outstanding	41.78M
Change %	+10.35%
Net Change	▲ 10.7200
Insider Ownership	N/A
Exchange	NYSE
Sector
Industry	PHARMACEUTICAL PREPARATIONS
IPO Year	2026
Country	United States
Underwriter	Jefferies, Leerink Partners, Citi, Cantor Fitzgerald, more

Type: All Buy Sale Start date: End date: Filter Reset

Date	Type	Amount Purchased	Purchaser
No records found.